IPO filing research

Kardigan, Inc.

Pharmaceutical Preparations

ipo amended Nasdaq S-1

Kardigan, Inc. IPO research page with SEC filing history, offering status, deal terms, structured filing extracts, company news, and comparable IPO context. Latest filing: S-1 on 2026-05-26. Current deal snapshot: exchange Nasdaq.

Filing Timeline

SEC EDGAR

S-1 filed

Initial registration statement

Initial public filing submitted to start the SEC review process.

Follows DRS/A in the pre-IPO sequence.

Common stock · Exchange Nasdaq · Ticker KARD · Use of proceeds General corporate purposes · Underwriters J.P. Morgan, Jefferies, Leerink Partners

Kardigan, Inc. is a clinical-stage biopharmaceutical company with significant financial losses, seeking to raise capital through its IPO. The filing outlines pro forma adjustments for a reverse stock split, conversion of preferred stock to common, and potential offering proceeds. The company has no revenue and relies on ongoing research and development for its lead product candidates: Danicamtiv, Ataciguat, and Tonlamarsen.

2026-05-26 · 0001193125-26-239298

DRS/A amended

Amended draft registration statement

Updated draft registration filed before the public launch.

Updates the prior DRS filing.

2026-05-04 · 0001193125-26-202951

DRS filed

Draft registration statement

Draft registration filed confidentially before the public launch.

First tracked pre-IPO filing for this issuer.

2026-03-26 · 0001193125-26-126541

Comparable Deals

14 comparable deals

Healthcare & BiotechLast 18 months

Only 0 strict matches; expanded to 14 using nearest neighbors.

Showing top 8 by similarity.

-0.3%

Median day-1

50%

Above issue

-3.0%

Median week-1

-20.9%

Downside (p10)

Seaport Therapeutics, Inc. SPTX

2026-05-01 $255M Day 1: +10.2% Wk 1: -13.9%

same SICrecent IPO

Avalyn Pharma Inc. AVLN

2026-04-30 $300M Day 1: +63.8% Wk 1: +53.9%

same SICrecent IPO

First Tracks Biotherapeutics, Inc. TRAX

2026-04-20 - Day 1: -9.3% Wk 1: -11.5%

same SICrecent IPO

Kailera Therapeutics, Inc. KLRA

2026-04-17 $625M Day 1: +62.5% Wk 1: +56.7%

same SICrecent IPO

Generate Biomedicines, Inc. GENB

2026-02-27 $400M Day 1: -20.9% Wk 1: -22.2%

same SICrecent IPO

Aardvark Therapeutics, Inc. AARD

2026-02-06 $94M Day 1: -20.9% Wk 1: -23.3%

same SICrecent IPO

Odyssey Therapeutics, Inc. ODTX

2026-05-08 $279M Day 1: -8.8% Wk 1: -3.8%

same SIC grouprecent IPO

Hemab Therapeutics Holdings, Inc. COAG

2026-05-01 $302M Day 1: +88.9% Wk 1: +43.0%

same SIC grouprecent IPO

Recent News

No recent news stored for this issuer.